Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Inventory: 2009-2025

Historic Change in Inventory for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$257,000.

  • Rockwell Medical's Change in Inventory fell 180.56% to -$257,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 361.73%. This contributed to the annual value of $332,000 for FY2024, which is 128.23% up from last year.
  • Per Rockwell Medical's latest filing, its Change in Inventory stood at -$257,000 for Q3 2025, which was up 70.96% from -$885,000 recorded in Q2 2025.
  • Rockwell Medical's 5-year Change in Inventory high stood at $1.5 million for Q1 2022, and its period low was -$1.6 million during Q3 2023.
  • Its 3-year average for Change in Inventory is -$247,182, with a median of -$190,000 in 2024.
  • As far as peak fluctuations go, Rockwell Medical's Change in Inventory skyrocketed by 1,056.86% in 2022, and later crashed by 999.30% in 2023.
  • Quarterly analysis of 5 years shows Rockwell Medical's Change in Inventory stood at $102,000 in 2021, then surged by 1,056.86% to $1.2 million in 2022, then crashed by 67.37% to $385,000 in 2023, then slumped by 99.74% to $1,000 in 2024, then plummeted by 180.56% to -$257,000 in 2025.
  • Its Change in Inventory stands at -$257,000 for Q3 2025, versus -$885,000 for Q2 2025 and -$733,000 for Q1 2025.